Interim / Quarterly Report • Nov 4, 2024
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 7504K
Commercial Intnl Bank (Egypt) SAE
03 November 2024
![]() |
Condensed Separate Interim Statement of Financial Position as at September 30, 2024
Notes
Sep. 30, 2024
Dec. 31, 2023
Assets
Cash and balances at the central bank
9
94,285,689
71,747,343
Due from banks
10
304,041,116
230,709,419
Loans and advances to banks, net
12
3,323,215
822,448
Loans and advances to customers, net
13
301,909,242
233,824,745
Derivative financial instruments
1,769,619
1,101,896
Financial investments
- Financial Assets at Fair Value through P&L
14
2,066,889
-
- Financial Assets at Fair Value through OCI
14
222,440,208
232,290,598
- Financial Assets at Amortized cost
14
144,700,921
37,847,114
- Investments in subsidiaries and associates
15
871,525
671,525
Non current assets held for sale
28
159,828
159,828
Other assets
16
34,217,526
18,929,067
Deferred tax assets
1,870,814
1,685,223
Property and equipment
17
2,999,072
2,737,936
Total assets
1,114,655,664
832,527,142
Liabilities and equity
Liabilities
Due to banks
18
3,820,953
12,427,384
Due to customers
19
896,692,273
675,310,076
Derivative financial instruments
138,896
140,934
Current income tax liabilities
14,269,506
9,395,534
Other liabilities
20
21,685,718
18,307,580
Issued debt instruments
21
4,811,742
3,073,349
Other loans
20,324,693
12,483,907
Other provisions
22
15,471,381
11,088,372
Total liabilities
977,215,162
742,227,136
Equity
Issued and paid up capital
30,431,580
30,195,010
Reserves
61,951,798
29,388,626
Reserve for employee stock ownership plan (ESOP)
1,667,230
1,486,010
Retained earnings *
43,389,894
29,230,360
Total equity and net profit for the period / year
137,440,502
90,300,006
Total liabilities and equity
1,114,655,664
832,527,142
The accompanying notes are an integral part of these financial statements.
( Limited Review report attached )
*
Including net profit for the period
| Condensed Separate Interim Income Statement for the period ended September 30, 2024 | ||||||||||
| Last 9 Months | Last 9 Months | |||||||||
| Notes | Sep. 30, 2024 | Sep. 30, 2023 | ||||||||
| Interest and similar income | 130,537,149 | 72,741,395 | ||||||||
| Interest and similar expense | (65,010,779) | (35,154,201) | ||||||||
| Net interest income | 65,526,370 | 37,587,194 | ||||||||
| Fee and commission income | 9,257,495 | 6,540,630 | ||||||||
| Fee and commission expense | (4,048,928) | (2,590,207) | ||||||||
| Net fee and commission income | 5,208,567 | 3,950,423 | ||||||||
| Dividend income | 100,858 | 100,244 | ||||||||
| Net trading income | 6 | 18,177,630 | 3,146,544 | |||||||
| Profits (Losses) on financial investments | 14.1 | 377,992 | (1,256,233) | |||||||
| Administrative expenses | (8,795,429) | (6,304,022) | ||||||||
| Other operating income (expenses) | 7 | (17,980,232) | (5,293,795) | |||||||
| Impairment release (charges) for credit losses | (3,741,208) | (1,248,897) | ||||||||
| Profit before income tax | 58,874,548 | 30,681,458 | ||||||||
| Income tax expense | 26 | (16,964,163) | (9,540,541) | |||||||
| Deferred tax assets (Liabilities) | 26 | 646,991 | 591,159 | |||||||
| Net profit for the period | 42,557,376 | 21,732,076 | ||||||||
| Earnings per share | 8 | |||||||||
| Basic | 12.42 | 6.41 | ||||||||
| Diluted | 12.26 | 6.33 | ||||||||
| Islam Zekry | Hisham Ezz Al-Arab | |||||||||
| Group CFO | Chairman | |||||||||
| Condensed Separate Interim Statement of Comprehensive Income for the period ended September 30, 2024 | ||||||||||
| Last 9 Months | Last 9 Months | |||||||||
| Sep. 30, 2024 | Sep. 30, 2023 | |||||||||
| Net profit for the period | 42,557,376 | 21,732,076 | ||||||||
| Change in fair value of Financial invesments measured at fair value through comprehensive income after tax | 8,284,110 | (9,611,703) | ||||||||
| Transferred to RE from financial assets at fair value through comprehensive income | (370,224) | (95,308) | ||||||||
| Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income | 624,524 | 197,888 | ||||||||
| Total comprehensive income for the period | 51,095,786 | 12,222,953 | ||||||||
| Condensed Separate Interim Cash Flows for the period ended September 30, 2024 | |||||
| Notes | Sep. 30, 2024 | Sep. 30, 2023 | |||
| Cash flow from operating activities | |||||
| Profit before income tax | 58,874,548 | 30,681,458 | |||
| Adjustments to reconcile profits to net cash provided by operating activities | |||||
| Fixed assets depreciation | 17 | 763,079 | 636,285 | ||
| Impairment Release/charge for credit losses (Loans and advances to customers and banks) | 4,226,051 | 1,088,174 | |||
| Other provisions Release/charge | 22 | 429,182 | 2,350,347 | ||
| Impairment Release/charge for credit losses (due from banks) | (5) | (49,019) | |||
| Impairment Release/charge for credit losses (financial investments) | (484,838) | 209,742 | |||
| Impairment Release/charge for other assets | (11,956) | 14,347 | |||
| Exchange revaluation differences for financial assets at fair value through OCI and AC | (18,536,183) | (5,409,592) | |||
| Revaluation differences Impairment charge for Financial Assets at Fair value through OCI | 1,199,896 | - | |||
| Revaluation differences Impairment charge for Financial Assets at Amortized cost | 107,207 | - | |||
| Revaluation differences Impairment charge for due from banks | 107 | - | |||
| Utilization of other provisions | 22 | (9,196) | (1,608) | ||
| Exchange revaluation differences of other provisions | 22 | 3,963,023 | 1,096,665 | ||
| Profits/losses from selling property and equipment | (2,254) | (194) | |||
| Profits/losses from selling financial investments at fair value through OCI | 14.1 | (377,992) | (149,012) | ||
| Losses (Profits) from selling investments in associates | 14.1 | - | (7,466) | ||
| Share based payments | 804,345 | 608,250 | |||
| Impairment Release/charges of investments in associates and subsidiaries | 14.1 | - | 1,412,711 | ||
| Operating profits before changes in operating assets and liabilities | 50,945,014 | 32,481,088 | |||
| Net decrease / increase in assets and liabilities | |||||
| Due from banks | (24,748,544) | 5,142,259 | |||
| Financial assets at fair value through P&L | (2,066,889) | - | |||
| Derivative financial instruments | (229,127) | 172,635 | |||
| Loans and advances to banks and customers | 12-13 | (74,803,105) | (27,805,660) | ||
| Other assets | (14,036,648) | (2,507,984) | |||
| Due to banks | 18 | (8,606,431) | 15,554,567 | ||
| Due to customers | 19 | 221,382,197 | 135,770,021 | ||
| Current income tax obligations paid | (2,694,657) | (2,547,087) | |||
| Other liabilities | (6,305,033) | 874,366 | |||
| Net cash generated from (used in) operating activities | 138,836,777 | 157,134,205 | |||
| Cash flow from investing activities | |||||
| Proceeds from sale of investments in associates | 11,956 | 2,119 | |||
| Payments for investment in subsidiaries | (200,000) | (1,216,022) | |||
| Payments for purchases of property, equipment and branches construction | (2,284,236) | (1,162,819) | |||
| Proceeds from selling property and equipment | 2,254 | 194 | |||
| Proceeds from redemption of financial assets at amortized cost | 1,093,724 | 5,278,030 | |||
| Payments for purchases of financial assets at amortized cost | (105,723,312) | (9,178,811) | |||
| Payments for purchases of financial assets at fair value through OCI | (21,646,713) | (65,109,765) | |||
| Proceeds from selling financial assets at fair value through OCI | 67,015,091 | 76,347,190 | |||
| Net cash generated from (used in) investing activities | (61,731,236) | 4,960,116 | |||
| Condensed Separate Interim Cash Flows for the period ended September 30, 2024 (Cont.) | |||||
| Sep. 30, 2024 | Sep. 30, 2023 | ||||
| Cash flow from financing activities | |||||
| Other loans | 7,840,786 | 2,408,739 | |||
| Dividends paid | (5,078,792) | (3,738,888) | |||
| Issued debt instruments | 1,738,393 | 615,227 | |||
| Capital increase | 236,570 | 369,876 | |||
| Net cash generated from (used in) financing activities | 4,736,957 | (345,046) | |||
| Net (decrease) increase in cash and cash equivalent during the period | 81,842,498 | 161,749,275 | |||
| Beginning balance of cash and cash equivalent | 233,912,193 | 92,895,143 | |||
| Cash and cash equivalent at the end of the period | 315,754,691 | 254,644,418 | |||
| Cash and cash equivalent comprise: | |||||
| Cash and balances at the central bank | 9 | 94,285,689 | 59,818,535 | ||
| Due from banks | 304,041,410 | 276,244,266 | |||
| Treasury bills and other governmental notes | 11 | 82,174,775 | 71,507,826 | ||
| Obligatory reserve balance with CBE | (76,128,521) | (52,853,882) | |||
| Due from banks with maturity more than three months | (17,846,556) | (29,659,932) | |||
| Treasury bills and other governmental notes with maturity more than three months | (70,772,106) | (70,412,395) | |||
| Total cash and cash equivalent | 315,754,691 | 254,644,418 | |||
| Condensed Separate Interim statement of changes in shareholders' equity | ||||||||||
| Issued and paid up capital | Legal reserve | General reserve | General risk reserve | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Total | |
| Sep. 30, 2023 | ||||||||||
| Beginning Balance at 1 January 2023 | 29,825,134 | 3,963,946 | 27,096,858 | 1,549,445 | 18,947 | (13,138,461) | 11,981 | 16,497,346 | 1,895,435 | 67,720,631 |
| Capital increase | 369,876 | - | - | - | - | - | - | - | - | 369,876 |
| Transferred to reserves | - | 806,408 | 12,743,849 | - | 2,208 | - | - | (12,388,223) | (1,164,242) | - |
| Dividend paid | - | - | - | - | - | - | - | (3,738,888) | - | (3,738,888) |
| Net profit for the period | - | - | - | - | - | - | - | 21,732,076 | - | 21,732,076 |
| Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | (95,308) | - | 95,308 | - | - |
| Net unrealised gain/(loss) on financial assets at fair value through OCI after tax | - | - | - | - | - | (9,611,703) | - | - | - | (9,611,703) |
| Transferred (from) to bank risk reserve | - | - | - | - | - | - | 3,249 | (3,249) | - | - |
| Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | 197,888 | - | - | - | 197,888 |
| Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | 608,250 | 608,250 |
| Balance at 30 September 2023 | 30,195,010 | 4,770,354 | 39,840,707 | 1,549,445 | 21,155 | (22,647,584) | 15,230 | 22,194,370 | 1,339,443 | 77,278,130 |
| Sep. 30, 2024 | ||||||||||
| Beginning Balance at 1 January 2024 | 30,195,010 | 4,770,354 | 39,840,707 | 1,549,445 | 21,155 | (16,808,265) | 15,230 | 29,230,360 | 1,486,010 | 90,300,006 |
| Capital increase | 236,570 | - | - | - | - | - | - | - | - | 236,570 |
| Transferred to reserves | - | 1,438,320 | 22,582,085 | - | 1,663 | - | - | (23,398,943) | (623,125) | - |
| Dividend paid | - | - | - | - | - | - | - | (5,366,429) | - | (5,366,429) |
| Net profit for the period | - | - | - | - | - | - | - | 42,557,376 | - | 42,557,376 |
| Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | (370,224) | - | 370,224 | - | - |
| Net unrealised gain/(loss) on financial assets at fair value through OCI after tax | - | - | - | - | - | 8,284,110 | - | - | - | 8,284,110 |
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | 2,694 | (2,694) | - | - |
| Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | 624,524 | - | - | - | 624,524 |
| Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | 804,345 | 804,345 |
| Balance at 30 September 2024 | 30,431,580 | 6,208,674 | 62,422,792 | 1,549,445 | 22,818 | (8,269,855) | 17,924 | 43,389,894 | 1,667,230 | 137,440,502 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
QRTBJBPTMTMMBJI
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.